Plain-English translation of NCT04043494 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This international trial is testing whether , a type of steroid, works better than (the standard steroid) at preventing lymphoma from returning in the brain and spinal cord in children and adolescents with newly diagnosed lymphoblastic lymphoma. The trial is also testing whether some children at higher risk of relapse benefit from more intensive treatment. Researchers hope to find ways to improve survival while managing side effects.
Lymphoblastic lymphoma is a serious blood cancer in children, and even with current treatments, some patients experience relapse, particularly in the brain and central nervous system. This trial aims to determine whether this medication can better prevent these brain-related relapses and whether intensified treatment helps certain higher-risk patients.
You likely qualify if…
You likely don't qualify if…
After joining the trial, you will be randomly assigned to receive either the standard steroid () or the new steroid () as part of your lymphoma treatment. Your treatment will unfold in phases over many months: a cytoreductive phase to shrink the cancer quickly, an induction phase, a consolidation phase, and additional phases depending on your risk group, followed by maintenance therapy to help prevent relapse. You will have regular clinic visits, blood tests, and imaging scans to monitor your response and manage side effects.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Austria